RxDoctor Payments Data

Brian Rayburn, PA

Physician Assistant · Little Rock, ARNPI 1144816430

Payments from drug & device makers

What this record shows

16 manufacturers reported payments, led by Boston Scientific at 34.8% of the total. Reporting peaked in 2023 at $2,848 and has fallen 93.4% since, to $188 in 2025.

$4,111in general payments, 2019–2025

Across 71 payments — averaging $57.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Teleflex LLC$1K
  • Endo Pharmaceuticals Inc.$826
  • Antares Pharma, Inc.$139
  • AstraZeneca$109
  • Novo Nordisk$94
  • plus $420 from 10 others

What the payments were for

  • Travel & lodging$1,79144%
  • Food & beverage$2,32056%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,111 in reported general payments places this provider in the 85th percentile of 451 physician assistant providers in Arkansas.

See all physician assistant providers in Arkansas

Medicare billing

Part B allowed, 2024
$115,533
Medicare patients
258
Services billed
13,322

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron13$5,903
Testosterone25$5,674
Testosterone Cypionate80$3,069
Trospium Chloride33$1,664
Tamsulosin Hcl75$1,135
Finasteride45$708
Oxybutynin Chloride11$456
Oxybutynin Chloride ErOxybutynin Chloride11$345
Tadalafil12$182
Anastrozole23$61
Ciprofloxacin Hcl13$56
Levofloxacin17$32
Prednisone11$9

Paid to pharmacies, not to this prescriber.

Other physician assistant in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →